Data / Drug companies / Face Reality, LLC
Face Reality, LLC: 16 products in the FDA NDC directory, labeler code 70707
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Face Reality, LLC (labeler code 70707) lists 16 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 16 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 9, 2026.
The request: Watch Face Reality, LLC (FDA labeler code 70707): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 70707
- Products in commercial distribution
- 16
- Packages
- 19
- Finished drugs by generic name
- 7
- Prescription products
- 0
- Over the counter products
- 16
- Flagged as original packager
- 15 of 15 products that carry the flag
- Started marketing in the last 12 months
- 3
- Products with a marketing end date set
- 2
- Earliest marketing start
- September 15, 2011
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 16 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 16 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Benzoyl peroxide | 10 | 82 |
| Salicylic acid | 1 | 330 |
| Zinc oxide, titanium dioxide | 1 | 44 |
| Sulfur | 1 | 52 |
| Homosalate, octisalate, avobenzone | 1 | 8 |
| Octocrylene, homosalate, octisalate, avobenzone | 1 | 17 |
| Zinc oxide | 1 | 595 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Gel | 7 | 43.8% |
| Cream | 7 | 43.8% |
| Shampoo, suspension | 2 | 12.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Copper Absorption Inhibitor | 2 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Face Reality Age Adaptive Clearing Serum Salicylic Acid Acne Treatment | 70707-457 | Gel | Over the counter monograph drugs | September 9, 2026 |
| Face Reality Power Mineral Sunscreen SPF 50 | 70707-456 | Cream | Over the counter monograph drugs | November 15, 2025 |
| Face Reality Brilliant Defense Sunscreen SPF 50 | 70707-455 | Cream | Over the counter monograph drugs | November 15, 2025 |
| Face Reality daily spf 30 plus Sunscreen SPF 30 | 70707-453 | Cream | Over the counter monograph drugs | January 17, 2025 |
| Face Reality mineral matte spf 28 Sunscreen SPF 28 | 70707-454 | Cream | Over the counter monograph drugs | October 1, 2024 |
| Face Reality 10% Advanced Acne Med | 70707-158 | Cream | Over the counter monograph drugs | March 24, 2024 |
| Face Reality 5% Advanced Acne Med | 70707-157 | Cream | Over the counter monograph drugs | March 24, 2024 |
| Face Reality Advanced Acne Med | 70707-156 | Cream | Over the counter monograph drugs | March 24, 2024 |
| Acne Med 10% | 70707-212 | Gel | Over the counter monograph drugs | January 1, 2023 |
| Acne Med 5% | 70707-211 | Gel | Over the counter monograph drugs | January 1, 2023 |
| Acne Med 2.5% | 70707-200 | Gel | Over the counter monograph drugs | January 1, 2023 |
| Sulfur Spot Treatment | 70707-440 | Gel | Over the counter monograph drugs | January 8, 2020 |
| Acne Face and Body Wash | 70707-711 | Shampoo, suspension | Over the counter monograph drugs | December 31, 2016 |
| 2.5 Acne Med | 70707-152 | Gel | Over the counter monograph drugs | November 23, 2011 |
| 10 Acne Med | 70707-151 | Gel | Over the counter monograph drugs | October 15, 2011 |
| Acne Face and Body | 70707-101 | Shampoo, suspension | Over the counter monograph drugs | September 15, 2011 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.